Gsk Share Discussion Threads

[zzaxx99] 12/7/2017 15:15

"Tough resistance" is a tad of an understatement - price hasn't managed a close over 1800 for about 16 years

[brancho] 12/7/2017 14:22

Bouncing off the trend line. More like 1900/2000 romeike but 1800 could be tough resisitance

[romeike] 12/7/2017 10:31

The next move up on news could take this to 1800

[tradermichael] 12/7/2017 10:04

And I think that would be a good move, so long as the price continues to be volatile.

[toffeeman] 12/7/2017 09:20

Well, when it gets back to 1710, I will be tempted to re-short.

[tradermichael] 12/7/2017 08:46

I think we all would. I bought on the way down and I'm full up now. Must admit, I didn't see this 5% fall. However, the price is able to 'recover' almost as quickly ...... ;0)

[ny boy] 11/7/2017 09:40

Support levels under 1600p, which is still holding.

1590p
1573p
1550p

I would like to add some more n that zone, if the market allows me.

[dr biotech] 10/7/2017 17:24

More than I normally make on my sb's

[tradermichael] 10/7/2017 11:43

But its only 7 points..... ;0)

[grahamite2] 10/7/2017 11:27

Thanks. Could come in useful for Scrabble.

[tradermichael] 10/7/2017 11:22

Well, in Indian currency, a crore is 10,000,000 rupees.
1 rupee is £0.012

[grahamite2] 10/7/2017 11:18

Still, what the hell's a crore?

[tradermichael] 10/7/2017 10:02

Yes, its India, near Mumbai (I think). Converts to a spend of £120 million?

[grahamite2] 10/7/2017 09:58

Interesting.

What's Rs 1,000 crore?

India - I assume that's what we're talking about - contributes 30% of global volume. What % does it contribute to the bottom line?

[tradermichael] 10/7/2017 09:57

Converts to a spend of £120 million?

[tradermichael] 10/7/2017 09:51

GlaxoSmithKline (GSK) Pharmaceuticals, a global healthcare company, is going to pour Rs 1,000 crore in its new pharma unit in Karnataka. The company is also looking at enhancing its global pipeline in segments such as vaccines and respiratory drugs in India.

The healthcare company is examining new possible products launches in the country from its global respiratory and vaccines pipeline and also reviewing complementary inorganic opportunities.

Almost 30% of the global pharmaceutical volumes sold by GSK is sold in the country.

The company is also upgrading its current Nashik facility. GSK India, in compliance with the GSK respiratory free strategy and the WHO requirement, has invested Rs 115 crore to construct a dedicated facility for the manufacturing of Eltroxin, which will be fully functional in 2018.

[alphorn] 07/7/2017 10:11

Forex this morning.

[ny boy] 07/7/2017 09:43

Another bounce off 1600p, hopefully a short term bottom.

[volsung] 06/7/2017 21:37

Grumpydrawers you need to wind your neck in big time. Comprende?

[chris1604] 06/7/2017 20:12

No he was a very good centre for Bradford Bulls

[alphorn] 06/7/2017 20:11

Correct! Thx!

[ianood] 06/7/2017 19:30

Is that David Redfearn the illusionist or David Redfern GSK's Chief Strategy Officer?

I hope it's the latter ;)

[alphorn] 06/7/2017 17:33

David Redfearn would know. ;)